Though not a blind study and no control group, its pretty sound method and supervision was appropriate for psychology standards.
its interesting that they chose escitalopram for the comparison. more interesting they gave a 1mcg dose to the escitalopram group. I dare say they would have taken blood samples during and after the doses to check metabolism and interactions with the anti-depressant. though this isn't mentioned. https://www.nejm.org/doi/full/10.1056/NEJMoa2032994
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-6155
-
-
- There are more pages in this discussion • 13,763 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)